Features
- Pure reverse transcriptase for cDNA synthesis
- High yields of first-strand cDNA
- High value for a fair price
Applications
- First-strand cDNA synthesis
- Generation of labeled cDNA
- RNA analysis by primer extension
Product Description
biotechrabbit MMuLV Reverse Transcriptase is an exceptionally pure DNA polymerase which uses RNA as a substrate and exhibits no measurable proofreading 3’→5′ exonuclease function. This enzyme performs cDNA synthesis by extending a DNA primer annealed to an RNA template; it can also make copies from a single-stranded DNA templates.
The enzyme is purified from a recombinant E. coli strain carrying the MMuLV reverse transcriptase gene.
|
Component |
Composition |
|
MMuLV Reverse Transcriptase |
MMuLV Reverse Transcriptase, 200 U/µl, in storage buffer containing 50% (v/v) glycerol. |
|
10× MMuLV RT Buffer |
Optimized 10× MMuLV Reverse Transcriptase reaction buffer. |
|
STORAGE |
-20°C (until expiry date – see product label) |
Unit Definition
One unit is the amount of enzyme activity that incorporates 1 nmole of dTTP into acid insoluble fraction in 10 minutes at 42°C when poly(A)+ RNA and oligo (dT)20 are used as template-primer.
Quality Control
Functional Assay
cDNA synthesis with specific primers, followed by quantitative PCR.
Exonuclease assay
Linearized lambda/HindII fragments are incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.
Endonuclease assay
lambda DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No degradation of DNA was observed.
Nick Activity
Supercoiled plasmid DNA is incubated with Reverse Transcriptase in a 50 µl reaction mixture for 4 h at 37°C. No conversion of covalently closed circular DNA to nicked DNA was detected.
E. coli genomic DNA contamination assay
A sample of Reverse Transcriptase is analyzed with specific primers targeting the 16S rRNA gene in qPCR for the presence of contaminating E. coli DNA. No E. coli DNA was detectable.
RNase Assay
A sample of the enzyme was incubated with a RNA template. RNase activity was not observed after agarose gel electrophoresis.
Prevention of cDNA synthesis reaction contamination
RNase contamination is an exceptional concern when working with RNA. RNase A, providing most threat to RNA integrity, is a highly stable contaminant of any laboratory. To prevent RNA from degradation and to minimize possibility of contamination during cDNA synthesis; follow the guidelines below:
- Use separate clean areas for preparation of the samples and the reaction mixture.
- DEPC-treat all tubes and pipette tips or use certified nuclease-free labware with aerosol filters.
- Wear fresh gloves when handling RNA and all reagents.
- Always assess the integrity of RNA prior to cDNA synthesis in denaturing agarose gel electrophoresis.
- Use RNase free water and other reagents.
- To prevent RNA from degradation, add Ribonuclease inhibitor (optional) in to the cDNA synthesis reaction (20 units for 20 µl reaction).
Typical cDNA synthesis reaction set up
- Thaw on ice and mix very well all reagents.
- Assemble and keep all reactions on ice.
- To use time and reagents effectively, always prepare master mix for multiple reactions. For a master mix volume, always calculate the number reactions that you need plus one additional.
- Combine the following in an RNase-free reaction tube:
|
Component |
Volume |
Final concentration |
|
dNTP Mix (10 mM each dNTP) |
4 µl |
2 mM (each dNTP) |
|
RNase Inhibitor, 40 U/µl (optional) |
1 µl |
2 U/µl |
|
Oligo (dT)12–18 (10 µM) – or Hexamer Primer (25 µM) – or Gene Specific Primer (10 µM) |
0.5 µl 1 µl 0.5 µl |
0.25 µM 1.25 µM 0.25 µM |
|
10× MMuLV RT Buffer |
2 µl |
1× |
|
RNA Template |
0.5–5 µg total RNA or 50–500 ng mRNA (polyA) |
|
|
MMuLV Reverse Transcriptase |
1 µl |
10 U/µl |
|
RNase-free water |
Variable |
|
|
Total volume |
20 µl |
|
- Mix and collect the drops by centrifuging briefly.
- When using
- Hexamer Primer, incubate 10 minutes at 25°C followed by 42°C for 45–60 minutes
- Oligo (dT) or gene-specific Primer incubate at 42°C for 45–60 minutes.
- Inactivate enzyme at 85°C for 10 minutes.
- Collect the drops by spinning briefly.
- Store products at –20°C or proceed to next step, like PCR or qPCR.
- Use maximum 10 µl of the cDNA synthesis reaction mix for PCR in 50 µl volume.
Anti-VEGF Neutralizing Antibody |
|||
| 79478-2 | BPS Bioscience | 100 g | EUR 460 |
|
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
|||
Anti-TIGIT Neutralizing Antibody |
|||
| 71340 | BPS Bioscience | 100 µg | EUR 565 |
|
Description: Human Anti-TIGIT neutralizing antibody recognizing the TIGIT binding region on immune cells. |
|||
Anti-PCSK9 Neutralizing Antibody |
|||
| 71207 | BPS Bioscience | 50 µg | EUR 555 |
|
Description: Neutralizing recombinant human antibody (IgG1) recognizing the LDLR binding region of human PCSK9. |
|||
Anti-VISTA Neutralizing Antibody |
|||
| 101293 | BPS Bioscience | 100 µg | EUR 450 |
|
Description: This human monoclonal antibody recognizes human V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA), and neutralizes its interaction with VSIG3 (also called IGSF11). VISTA is also known as B7-H5 or VSIR (GenBank Accession No. NM_022153). VSIG3 is a ligand involved in cell adhesion as a VISTA binding partner. This neutralizing antibody has been functionally tested using the VSIG-3:VISTA [Biotinylated] Inhibitor Screening Assay Kit (BPS Bioscience #79782). |
|||
Anti-RANKL Neutralizing Antibody |
|||
| 100874-1 | BPS Bioscience | 50 µg | EUR 335 |
|
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain). |
|||
Anti-RANKL Neutralizing Antibody |
|||
| 100874-2 | BPS Bioscience | 100 µg | EUR 460 |
|
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain). |
|||
Anti-PD-1 Neutralizing Antibody |
|||
| 71120 | BPS Bioscience | 100 µg | EUR 465 |
|
Description: Neutralizing recombinant murine/human chimeric antibody recognizing the PD-L1/PD-L2 binding region of human PD-1. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
|||
Anti-IL-17A Neutralizing Antibody |
|||
| 91015 | BPS Bioscience | 100 µg | EUR 490 |
|
Description: Neutralizing recombinant human_x000D_chimeric antibody recognizing human IL-17A._x000D_This antibody has not been tested for crossreactivity_x000D_with other species. |
|||
Interferon alpha Neutralizing Antibody |
|||
| 20-abx137013 | Abbexa |
|
|
Anti-β-Amyloid Neutralizing Antibody |
|||
| 71223 | BPS Bioscience | 100 µg | EUR 465 |
|
Description: Purified, recombinant, humanized Anti-β-amyloid (IgG1) antibody, expressed in HEK293 cells. This antibody reacts with human β-amyloid and has not been tested for cross-reactivity with other species. |
|||
Anti-CTLA4 (CD152) Neutralizing Antibody |
|||
| 71212 | BPS Bioscience | 100 µg | EUR 490 |
|
Description: Neutralizing recombinant human monoclonal antibody recognizing the extracellular domain of CTLA4 and blocking binding of CTLA4 to B7.1 and B7.2. This antibody recognizes human CTLA4 but does not bind to murine CTLA4. This antibody has not been tested for cross-reactivity with other species. |
|||
Anti-PD-L1 (CD274) Neutralizing Antibody |
|||
| 71213 | BPS Bioscience | 100 µg | EUR 505 |
|
Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested. |
|||
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
| AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
|||
Anti-PD-1 Neutralizing Antibody, Biotin-labeled |
|||
| 71215 | BPS Bioscience | 100 µg | EUR 510 |
|
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
|||
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
| 100436-1 | BPS Bioscience | 50 µg | EUR 355 |
|
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
|||
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
| 100436-2 | BPS Bioscience | 100 µg | EUR 490 |
|
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
|||
Anti-PD-L1 Neutralizing Antibody, Biotin-labeled |
|||
| 71214 | BPS Bioscience | 100 µg | EUR 510 |
|
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species. |
|||
Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2) |
|||
| 101326 | BPS Bioscience | 100 µg | EUR 600 |
|
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339). |
|||
Spike Neutralizing Antibody (Clone G10xA5) (SARS-CoV-2) |
|||
| 101327 | BPS Bioscience | 100 µg | EUR 600 |
|
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience, #78339). |
|||
Anti-PCSK9 Neutralizing Antibody, (IgG1) Biotin-labeled |
|||
| 71216 | BPS Bioscience | 50 µg | EUR 530 |
|
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
|||
Anti-PCSK9 Neutralizing Antibody, (IgG4) Biotin-labeled |
|||
| 71217 | BPS Bioscience | 50 µg | EUR 515 |
|
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
|||
D E Neutralizing Bt 500gm |
|||
| 281910 | Scientific Laboratory Supplies | EACH | EUR 211.2 |
Spike S1 Neutralizing Antibody (SARS-CoV-2) (Clone: 414-2) |
|||
| 100792 | BPS Bioscience | 100 µg | EUR 460 |
|
Description: Recombinant human monoclonal (clone 414-2) antibody recognizing the SARS-CoV-2 Spike S1 RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus. |
|||
Spike S1 Neutralizing Antibody (SARS-CoV-2) (Clone: 414-1) |
|||
| 100793 | BPS Bioscience | 100 µg | EUR 485 |
|
Description: Recombinant human monoclonal (clone 414-1) antibody recognizing the SARS-CoV-2 Spike S1 RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus. |
|||
Neutralizing Buffer 100gm |
|||
| 236210 | Scientific Laboratory Supplies | EACH | EUR 85.2 |
D/E NEUTRALIZING AGAR |
|||
| D04-112-10kg | Alphabiosciences | 10 kg | EUR 1843.2 |
D/E NEUTRALIZING AGAR |
|||
| D04-112-2Kg | Alphabiosciences | 2 Kg | EUR 447.6 |
D/E NEUTRALIZING AGAR |
|||
| D04-112-500g | Alphabiosciences | 500 g | EUR 165.6 |
Spike Neutralizing Antibody (Clone LxC1-G10) (SARS-CoV-2) |
|||
| 101246 | BPS Bioscience | 100 µg | EUR 545 |
|
Description: This human monoclonal antibody recognizes SARS-CoV-2 full-length spike proteins in the native trimeric conformation. This antibody cross-reacts with the wildtype (BPS Bioscience #100728) as well as the Alpha B.1.1.7 (BPS Bioscience #510334), Beta B.1.351 (BPS Bioscience #510333), Beta B.1.351Δ242-244 (BPS Bioscience #101091), Gamma P.1 (BPS Bioscience #100989), Delta B.1.617.2 (BPS Bioscience #101147) and Delta Plus B.1.617.2.1 (BPS Bioscience #101165) variant spike trimers [Table of variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using BPS Bioscience Spike Trimer: ACE2 Inhibitor Screening Kits (available for purchase). |
|||
D/E NEUTRALIZING BROTH |
|||
| D04-115-10kg | Alphabiosciences | 10 kg | EUR 1210.8 |
D/E NEUTRALIZING BROTH |
|||
| D04-115-2kg | Alphabiosciences | 2kg | EUR 309.6 |